Novavax Says Coronavirus Vaccine Generated 'Robust Antibody Responses' In Phase 1 Trial ParticipantsBenzinga • 08/05/20
Novavax's Coronavirus Vaccine Induced Antibodies in 100% of Phase 1 Trial ParticipantsThe Motley Fool • 08/05/20
Novavax Stocks Jumps 8.5% After ‘Positive’ Early Results For Its Coronavirus VaccineForbes • 08/05/20
Novavax's coronavirus vaccine generates promising immune response in early trial, data showsCNBC • 08/04/20
Will Novavax (NVAX) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/29/20